Literature DB >> 24389219

Osteoclastogenesis and osteoimmunology.

Wei Feng1, Wei Xia1, Qing Ye1, Weibing Wu1.   

Abstract

Bone is continuously renewed through a dynamic balance between bone resorption and formation and is the fundamental basis for maintaining normal bone mass and architecture by osteoclasts (bone resorption) and osteoblasts (bone formation). Bone resorption is an elementary cellular activity in the modeling of the skeleton during growth and development. Later in life, bone remodeling occurs, and is locally initiated by resorption. During remodeling, bone resorption is coupled to new bone formation, that ensures bone renewal with only minor and temporary local bone loss. Osteoclasts play a crucial role in both physiological and pathological bone resorption, and receptor activator of nuclear factor-κB ligand is the key cytokine that induces osteoclastogenesis. At the same time, various factors produced during immune responses are capable of profoundly affecting bone regulation; bone and immune systems share an abundance of molecules and regulatory mechanisms. We summarize the new insights on the link between osteoclastogenesis and osteoimmunology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24389219     DOI: 10.2741/4242

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  10 in total

Review 1.  A novel miR17/protein tyrosine phosphatase-oc/EphA4 regulatory axis of osteoclast activity.

Authors:  Kin-Hing William Lau; Matilda H-C Sheng
Journal:  Arch Biochem Biophys       Date:  2018-05-17       Impact factor: 4.013

2.  FTY720 inhibited proinflammatory cytokine release and osteoclastogenesis induced by Aggregatibacter actinomycetemcomitans.

Authors:  Hong Yu; Bethany A Herbert; Michael Valerio; Leigh Yarborough; Li-Chien Hsu; Kelley M Argraves
Journal:  Lipids Health Dis       Date:  2015-07-04       Impact factor: 3.876

3.  Targeting stem cell niche can protect hematopoietic stem cells from chemotherapy and G-CSF treatment.

Authors:  Sidan Li; Dehui Zou; Changhong Li; Hengxing Meng; Weiwei Sui; Sizhou Feng; Tao Cheng; Qiongli Zhai; Lugui Qiu
Journal:  Stem Cell Res Ther       Date:  2015-09-15       Impact factor: 6.832

4.  Massive elimination of multinucleated osteoclasts by eupatilin is due to dual inhibition of transcription and cytoskeletal rearrangement.

Authors:  Ju-Young Kim; Myeung Su Lee; Jong Min Baek; Jongtae Park; Byung-Soo Youn; Jaemin Oh
Journal:  Bone Rep       Date:  2015-10-08

Review 5.  The role of Rho GTPases' substrates Rac and Cdc42 in osteoclastogenesis and relevant natural medicinal products study.

Authors:  Yuan Liu; Yusheng Dou; Liang Yan; Xiaobin Yang; Baorong He; Lingbo Kong; Wanli Smith
Journal:  Biosci Rep       Date:  2020-07-31       Impact factor: 3.840

Review 6.  Immune Modulation by Transplanted Calcium Phosphate Biomaterials and Human Mesenchymal Stromal Cells in Bone Regeneration.

Authors:  Paul Humbert; Meadhbh Á Brennan; Noel Davison; Philippe Rosset; Valérie Trichet; Frédéric Blanchard; Pierre Layrolle
Journal:  Front Immunol       Date:  2019-04-02       Impact factor: 7.561

Review 7.  Overview of RAW264.7 for osteoclastogensis study: Phenotype and stimuli.

Authors:  Lingbo Kong; Wanli Smith; Dingjun Hao
Journal:  J Cell Mol Med       Date:  2019-03-20       Impact factor: 5.310

Review 8.  Multi-functional osteoclasts in matrix-based tissue engineering bone.

Authors:  Yue-Qi Chen; Wen-Hui Hu; Zi-Cai Dong; Shi-Wu Dong
Journal:  Chin J Traumatol       Date:  2021-11-26

9.  Regulatory T cell-mediated anti-inflammatory effects promote successful tissue repair in both indirect and direct manners.

Authors:  Hong Lei; Katharina Schmidt-Bleek; Anke Dienelt; Petra Reinke; Hans-Dieter Volk
Journal:  Front Pharmacol       Date:  2015-09-02       Impact factor: 5.810

Review 10.  The Roles of Acidosis in Osteoclast Biology.

Authors:  Feng-Lai Yuan; Ming-Hui Xu; Xia Li; He Xinlong; Wei Fang; Jian Dong
Journal:  Front Physiol       Date:  2016-06-24       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.